New drug aims to tame severe gut inflammation

NCT ID NCT06850727

Summary

This study is testing a new drug called OD-07656 for people with moderate to severe ulcerative colitis. The main goals are to see if it is safe and if it can reduce symptoms like bleeding and diarrhea. Researchers also want to find out if taking OD-07656 first makes a standard treatment (vedolizumab) work better for patients.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS (UC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Alfred Health

    RECRUITING

    Melbourne, 3004, Australia

    Contact

  • CHUM

    RECRUITING

    Montreal, H2X OA9, Canada

    Contact

  • CHUM - Pavillon R

    RECRUITING

    Polička, 1549, Czechia

    Contact

  • Centrum Medyczne

    RECRUITING

    Bydgoszcz, Poland

    Contact

  • Centrum Medyczne LukaMed

    RECRUITING

    Chojnice, Poland

    Contact

  • Centrum Medyczne Medyk

    RECRUITING

    Rzeszów, Poland

    Contact

  • Coastal Digestive Health

    RECRUITING

    Maroochydore, Australia

    Contact

  • Danylo Halytsky Lviv National Medical University

    RECRUITING

    Lviv, 79000, Ukraine

    Contact

  • Eastern Health

    RECRUITING

    Box Hill, Australia

    Contact

  • Endoskopia Sp. z.o.o

    RECRUITING

    Sopot, Poland

    Contact

  • Fiona Stanley Hospital

    RECRUITING

    Murdoch, 6150, Australia

    Contact

  • IMSP Spitalul Clinic Republican Timofei Moneaga

    RECRUITING

    Chisinau, Md-2025, Moldova

    Contact

  • Irbid Specialty Hospital

    RECRUITING

    Irbid, 21110, Jordan

    Contact

  • Jordan University Hospital

    RECRUITING

    Amman, 11942, Jordan

    Contact

  • Lviv Regional Clinical Hospital

    RECRUITING

    Lviv, 79010, Ukraine

    Contact

  • Medical Network Company

    RECRUITING

    Warsaw, Poland

    Contact

  • Medical University of Graz

    RECRUITING

    Graz, Austria

    Contact

  • Medical centre of ARENSIA Exploratory Medicine LCC

    RECRUITING

    Kyiv, 01135, Ukraine

    Contact

  • Montreal General Hospital/McGill University

    RECRUITING

    Montreal, Canada

    Contact

  • Nowe zdrowie-CK, Kiełtucki

    RECRUITING

    Staszów, Poland

    Contact

  • PCRN Auckland

    RECRUITING

    Auckland, 0622, New Zealand

    Contact

  • PCRN Christchurch

    RECRUITING

    Christchurch, 0622, New Zealand

    Contact

  • PCRN Tasman

    RECRUITING

    Nelson, 7011, New Zealand

    Contact

  • PCRN Waikato

    RECRUITING

    Hamilton, 3200, New Zealand

    Contact

  • PCRN Wellington

    RECRUITING

    Upper Hutt, 5018, New Zealand

    Contact

  • Penta Hospitals Przychodnie

    RECRUITING

    Wroclaw, 54-239, Poland

    Contact

  • Regional Clinical Hospital

    RECRUITING

    Ivano-Frankivsk, 76008, Ukraine

    Contact

  • Royal Melbourne Hospital

    RECRUITING

    Parkville, Australia

    Contact

  • Sunshine Coast University

    RECRUITING

    Birtinya, Australia

    Contact

  • The Hospital of Lithuanian University of Health Sciences

    RECRUITING

    Kaunas, Lithuania

    Contact

  • The Specialty Hospital (TSH) / Advanced Clinical Center

    RECRUITING

    Amman, Jordan

    Contact

  • Vita Longa Sp. z.o.o.

    RECRUITING

    Katowice, Poland

    Contact

Conditions

Explore the condition pages connected to this study.